Speeches & Communication

Comments on Trials Before Patent Trial & Appeal Board

PhRMA November 18, 2015

The Pharmaceutical Research and Manufacturers of America (PhRMA) appreciates the opportunity to submit comments in connection with the Patent and Trademark Office‘s (PTO) or Office Request for Comments on Amendments to the Rules of Practice for Trials Before the Patent Trial and Appeal Board (PTAB or Board). 

PhRMA‘s member companies are leading research-based pharmaceutical innovators devoted to developing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA‘s membership ranges in size from small emerging companies to multi-national corporations that employ tens of thousands of Americans, and encompasses both research-based pharmaceutical and biotechnology companies. The U.S. biopharmaceutical sector supports a total of 3.4 million jobs throughout the economy, and directly employs more than 810,000 Americans. The industry‘s overall economic impact is substantial, accounting for nearly $800 billion in economic output.

Download